Compare EXPE & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXPE | HLN |
|---|---|---|
| Founded | 1996 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Transportation Services | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.4B | 41.7B |
| IPO Year | 1999 | N/A |
| Metric | EXPE | HLN |
|---|---|---|
| Price | $287.80 | $10.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 27 | 1 |
| Target Price | ★ $259.80 | N/A |
| AVG Volume (30 Days) | 1.6M | ★ 10.4M |
| Earning Date | 02-05-2026 | 07-31-2025 |
| Dividend Yield | 0.56% | ★ 1.80% |
| EPS Growth | 35.97 | ★ 41.64 |
| EPS | ★ 10.37 | 0.23 |
| Revenue | $14,370,000,000.00 | ★ $15,096,588,575.00 |
| Revenue This Year | $8.72 | $1.51 |
| Revenue Next Year | $7.18 | $4.67 |
| P/E Ratio | ★ $27.63 | $44.16 |
| Revenue Growth | ★ 7.29 | N/A |
| 52 Week Low | $130.01 | $8.71 |
| 52 Week High | $292.42 | $11.42 |
| Indicator | EXPE | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 65.87 | 66.93 |
| Support Level | $286.15 | $9.82 |
| Resistance Level | $292.42 | $9.65 |
| Average True Range (ATR) | 6.72 | 0.13 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 84.89 | 97.09 |
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2024 sales), air tickets (3%), rental cars, cruises, in-destination, and other (10%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and alternative accommodations brand Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.